Corrigendum: IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation. Biomolecules and Biomedicine, [S. l.], v. 23, n. 3, p. 545, 2023. DOI: 10.17305/bb.2022.8739. Disponível em: https://www.bjbms.org/ojs/index.php/bjbms/article/view/8739. Acesso em: 29 may. 2023.